INTERNATIONAL : PHARMACEUTICAL SECTOR - REGULATION - COMPETITION LAW

Pharmaceutical sector in Europe : Conference DP-Concurrence, 29 April 2004 on sectoral regulation and competition

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. We will first make a point of regulation (reporting the remarks of Noël Renaudin, President of the Health Products Committee) (I) then an economic point of the drug distribution system (reporting the remarks of Patrick Rey, Professor of Economics at the University of Toulouse I) (II) and finally a legal point (reporting the remarks of Yan Forrester, international lawyer, Brussels) (III). I - Regulatory point We will make a quick presentation of the specificities of the drug market (A) and French regulations (B) before considering the possibilities of Community harmonisation (C). A - Presentation of the specificities of the drug market The drug market

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Marie Koehler de Montblanc, Pharmaceutical sector in Europe : Conference DP-Concurrence, 29 April 2004 on sectoral regulation and competition, December 2004, Concurrences N° 1-2004, Art. N° 26846, www.concurrences.com

Visites 2243

All reviews